Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
₹12 Cr
EMD Value
₹23.9 L
Closing Date
18 Nov 2025, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD, AMSCL
AMSCL
EDl Drugs
2025_HFWD_47235_1
Group No 7
Open Tender
Medicines
Supply
60 days
AMSCL
Please refer Tender documents.
2 documents required · 2 mandatory
₹2,000
₹23.9 L
Yes
2 Sept 2025
2 Sept 2025
18 Nov 2025
2 Sept 2025
18 Nov 2025
2 Sept 2025
Enoxaparin Injection 40 mg/0.4 ml , 0.4 ml pre-filled syringe unit
Heparin Injection 1000 IU/ml , 5 ml Vial
Phytomenadione (Vitamin K1) Injection 1 mg/ml, 1 ml Amp
Phytomenadione (Vitamin K1) Injection 10 mg/ml, 1 ml Amp
Tranexamic acid Tablet 500 mg , 1X10
Tranexamic acid Injection 100 mg/ml, 5 ml Amp
Warfarin Tablet 1mg, 1X10
Plasma Expander Infusion Infusion Hydroxy Ethyl Starch (130/0.4) 6% in plasma adapted solution., 500 ml Plastic Bottle /Free Flex Bag
Recombinant Factor VIIa Injection 1mg, Vial
Acetylsalicylic acid (A)+Clopidogrel(B) Tablet (A)150 mg+(B)75 mg, 1x10
Reteplase Injection 18 mg , Vial
Deferasirox Tablet 400mg, 1x6/1x10
Deferasirox Tablet 100mg, 1x6/1x10
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.42 MB
tender7.pdf
Tender Documents • 2.84 MB
BOQ_75360.xls
BOQ • 0.40 MB
17ExtenGP.pdf
PDF • 0.65 MB
16eXT.pdf
PDF • 0.66 MB
15ExtenGp.pdf
PDF • 0.30 MB
14extenPrebid3.pdf
PDF • 0.45 MB
13ExtensionGP1to15.pdf
PDF • 0.41 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .